These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30541064)

  • 1. Extracorporeal immunoadsorption in heparin- and protamine-induced thrombocytopaenia prior to cardiac surgery.
    Füreder L; Böhmig GA; Schaefer AK; Steinlechner B
    Eur J Cardiothorac Surg; 2019 Jul; 56(1):206-207. PubMed ID: 30541064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial.
    Miles LF; Burt C; Arrowsmith J; McKie MA; Villar SS; Govender P; Shaylor R; Tan Z; De Silva R; Falter F
    PLoS Med; 2021 Jun; 18(6):e1003658. PubMed ID: 34097705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protamine reduces whole blood platelet aggregation after cardiopulmonary bypass.
    Olsson A; Alfredsson J; Håkansson E; Svedjeholm R; Berglund J; Berg S
    Scand Cardiovasc J; 2016; 50(1):58-63. PubMed ID: 26402229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review.
    Boer C; Meesters MI; Veerhoek D; Vonk ABA
    Br J Anaesth; 2018 May; 120(5):914-927. PubMed ID: 29661409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
    Shore-Lesserson L; Reich DL; DePerio M
    Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
    Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heparin-protamine interaction. A review.
    Carr JA; Silverman N
    J Cardiovasc Surg (Torino); 1999 Oct; 40(5):659-66. PubMed ID: 10596998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass.
    Lee GM; Welsby IJ; Phillips-Bute B; Ortel TL; Arepally GM
    Blood; 2013 Apr; 121(15):2828-35. PubMed ID: 23422751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin removal after cardiopulmonary bypass in a patient with adverse reaction to protamine.
    Tevaearai HT; Jegger D; Mueller XM; Horisberger J; von Segesser LK
    Thorac Cardiovasc Surg; 1998 Oct; 46(5):303-4. PubMed ID: 9885123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
    Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating protamine-heparin-antibodies lead to higher protamine demand in patients undergoing cardiac surgery.
    Grieshaber P; Bakchoul T; Wilhelm J; Wagner A; Wollbrück M; Böning A; Sachs U
    J Thorac Cardiovasc Surg; 2015 Oct; 150(4):967-73.e1. PubMed ID: 26298870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protamine-Induced Coronary Graft Thrombosis: A Review.
    Chandiramani AS; Jenkin I; Botezatu B; Harky A
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt A):2679-2684. PubMed ID: 34774407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
    Dyke CM; Smedira NG; Koster A; Aronson S; McCarthy HL; Kirshner R; Lincoff AM; Spiess BD
    J Thorac Cardiovasc Surg; 2006 Mar; 131(3):533-9. PubMed ID: 16515902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined approach to treat heparin-induced thrombocytopaenia before heart transplant.
    Sandoval E; Lozano M; Pereda D; Quintana E; Cid J; García-Álvarez A; Fernández-Cisneros A; Castellá M
    Interact Cardiovasc Thorac Surg; 2020 Dec; 31(6):881-883. PubMed ID: 33155030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-protamine-heparin antibodies: incidence, clinical relevance, and pathogenesis.
    Bakchoul T; Zöllner H; Amiral J; Panzer S; Selleng S; Kohlmann T; Brandt S; Delcea M; Warkentin TE; Sachs UJ; Greinacher A
    Blood; 2013 Apr; 121(15):2821-7. PubMed ID: 23325832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protamine-induced immune thrombocytopenia.
    Singla A; Sullivan MJ; Lee G; Bartholomew J; Kapadia S; Aster RH; Curtis BR
    Transfusion; 2013 Oct; 53(10):2158-63. PubMed ID: 23384227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Triple HIT: Perioperative Management of Heparin-Induced Thrombocytopenia Using Plasma Exchange, Intravenous Immunoglobulin, and Protamine Infusion for Left Ventricular Assist Device Implantation.
    Liu VC; Klompas AM; Stulak JM; Yalamuri SM
    J Cardiothorac Vasc Anesth; 2022 Jun; 36(6):1715-1719. PubMed ID: 33933367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph.
    Khan NU; Wayne CK; Barker J; Strang T
    Eur J Anaesthesiol; 2010 Jul; 27(7):624-7. PubMed ID: 20485179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for improving the functionality of an affinity bioreactor.
    Wang T; Yang Z; Emregul E; David A; Balthasar JP; Liang J; Yang VC
    Int J Pharm; 2005 Dec; 306(1-2):132-41. PubMed ID: 16246511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention.
    Patel AA; White CM; Coleman CI
    Conn Med; 2007 Feb; 71(2):93-5. PubMed ID: 17393902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.